Department of Cardiovascular Surgery, Gansu Province, Gansu Provincial Hospital, No. 204, Donggang West Road, Lanzhou, 730000, China.
Gansu International Scientific and Technological Cooperation Base of Diagnosis and Treatment of Congenital Heart Disease, Lanzhou, China.
J Cardiothorac Surg. 2023 Jan 17;18(1):31. doi: 10.1186/s13019-023-02123-6.
The effect of gender on patients with mitral valve regurgitation (MR) undergoing transcatheter mitral valve repair (TMVR) remains to be defined. The aim of the present study is a comprehensive meta-analysis of studies that investigate differences between men and women after TMVR.
A systematic literature search was carried out on eight databases to collect all relevant studies on gender-related outcomes of TMVR before March 1, 2021. The main outcomes of interest were mortality, cardiac function, MR class and other complications.
A total of eight literatures were included, all of which were retrospective observational studies. Compared to women patients, men had lower postoperative New York Heart Association (NYHA) class (OR = 1.53, 95%CI [1.23, 1.91], P = 0.0001) and higher incidence of postoperative acute kidney injury (AKI) (OR = 1.25, 95%CI [1.16, 1.34], P < 0.05). There were no significant difference on mortality in 30 days (OR = 0.95, 95%CI [0.81, 1.11], P = 0.53) and in 2 years (OR = 0.99, 95%CI [0.75, 1.30], P = 0.93), mitral valve regurgitation (MR) class (OR = 1.30, 95%CI [0.97, 1.75], P = 0.08) and incidence of myocardial infarction (MI) (OR = 0.88, 95%CI [0.65, 1.18], P = 0.38), stroke (OR = 0.80, 95%CI [0.63, 1.02], P = 0.08) and bleeding in hospital (OR = 0.84, 95%CI [0.59, 1.19], P = 0.32).
Our meta-analysis demonstrates that men undergoing TMVR have worse preoperative diseases (diabetes mellitus, coronary artery disease, renal failure and myocardial infarction) while they have superior postoperative NYHA class at one-year. There are no significantly difference in other indexes between men and women.
性别对行经导管二尖瓣修复术(TMVR)的二尖瓣反流(MR)患者的影响仍有待确定。本研究的目的是对研究 TMVR 后男性和女性之间差异的所有研究进行综合荟萃分析。
系统地在八个数据库中进行文献检索,以收集 2021 年 3 月 1 日之前所有与 TMVR 性别相关结局相关的研究。主要观察指标为死亡率、心功能、MR 分级和其他并发症。
共纳入 8 项文献,均为回顾性观察性研究。与女性患者相比,男性患者术后纽约心脏协会(NYHA)心功能分级较低(OR=1.53,95%CI[1.23,1.91],P=0.0001),术后急性肾损伤(AKI)发生率较高(OR=1.25,95%CI[1.16,1.34],P<0.05)。30 天(OR=0.95,95%CI[0.81,1.11],P=0.53)和 2 年(OR=0.99,95%CI[0.75,1.30],P=0.93)死亡率、MR 分级(OR=1.30,95%CI[0.97,1.75],P=0.08)和心肌梗死(MI)发生率(OR=0.88,95%CI[0.65,1.18],P=0.38)、卒中(OR=0.80,95%CI[0.63,1.02],P=0.08)和住院出血(OR=0.84,95%CI[0.59,1.19],P=0.32)无显著差异。
我们的荟萃分析表明,接受 TMVR 的男性患者术前疾病(糖尿病、冠状动脉疾病、肾衰竭和心肌梗死)更严重,但术后 1 年 NYHA 心功能分级更高。男性和女性在其他指标上没有显著差异。